Bulldog Investors’s Jasper Therapeutics JSPR Stock Holding History

Bulldog Investors’s Portfolio JSPR Stock Details JSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-27,797	Closed	-$2.76M	–	263
2021 Q2	$2.76M	Sell	27,797 -159	-0.6%	-$15.8K	0.74%	45
2021 Q1	$2.77M	Buy	27,956 +3,341	+14%	+$340K	0.81%	39
2020 Q4	$2.46M	Sell	24,615 -210	-0.8%	-$20.9K	0.91%	38
2020 Q3	$2.46M	Sell	24,825 -175	-0.7%	-$17.5K	0.79%	31
2020 Q2	$2.5M	Hold	25,000	–	–	1.12%	29
2020 Q1	$2.39M	Buy	+25,000	New	+$2.45M	1.26%	25

Other funds holding JSPR

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPARFS

Leverage Partners Absolute Return Fund SPC Cayman Islands Ky1-11111, Cayman Islands $54K AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bulldog Investors's JSPR Position: Q3 2021 in Review

Bulldog Investors sold out of Jasper Therapeutics (JSPR) in Q3 2021, closing a stake of 27,797 shares — an estimated $2.76M sold.

Bulldog Investors first reported a position in JSPR in Q1 2020 and held it in 6 quarters. The position peaked at $2.77M in Q1 2021. 10 funds tracked by Wall St. Rank hold JSPR as of Q3 2021.

Bulldog Investors reported no remaining Jasper Therapeutics position as of Q3 2021 after selling out during the quarter.
Bulldog Investors sold 27,797 Jasper Therapeutics shares in Q3 2021, an estimated $2.76M.
Bulldog Investors first reported a position in Jasper Therapeutics in Q1 2020 and held it in 6 quarters.
Bulldog Investors's Jasper Therapeutics position peaked at $2.77M in Q1 2021.
10 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2021.

Based on Bulldog Investors's 13F filing for Q3 2021, filed 12 Nov 2021.